Literature DB >> 9739390

[Value of radiotherapy of residual tumors after chemotherapy of metastatic seminomas].

M Bamberg, J Classen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9739390     DOI： 10.1007/bf03038572

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Sites of relapse in seminoma treated with single agent carboplatin chemotherapy: implications for further management.

Authors:  D MacVicar; A Horwich
Journal:  Clin Oncol (R Coll Radiol)       Date:  1992-07       Impact factor: 4.126

Review 2.  [An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors].

Authors:  M Bamberg; H J Schmoll; L Weissbach; J Beyer; C Bokemeyer; A Harstrick; W Höltl; R Souchon; H Vogler
Journal:  Strahlenther Onkol       Date:  1997-08       Impact factor: 3.621

3.  Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.

Authors:  G M Duchesne; S P Stenning; N Aass; G M Mead; S D Fosså; R T Oliver; A Horwich; G Read; I T Roberts; G Rustin; M H Cullen; S B Kaye; S J Harland; P A Cook
Journal:  Eur J Cancer       Date:  1997-05       Impact factor: 9.162

4.  Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center.

Authors:  H S Puc; R Heelan; M Mazumdar; H Herr; J Scheinfeld; V Vlamis; D F Bajorin; G J Bosl; P Mencel; R J Motzer
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544
  4 in total
  1 in total

1.  [Reduced morbidity in resection of residual tumors after chemotherapy for seminoma].

Authors:  D Pfister; D Porres; V Matveev; A Heidenreich
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.